Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Yuan Bai

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphomaChing-Yun Hsieh, Hsin-Hui Huang, Chen-Yuan Lin, et al.
Journal of Medicinal Chemistry|August 10, 2011
Identification and characterization of a novel integrin-linked kinase inhibitorSu-Lin Lee, En-Chi Hsu, Chih-Chien Chou, et al.
Oncotarget|April 19, 2017
OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signalingWan-Chi Tsai, Li-Yuan Bai, Yi-Jin Chen, et al.
Journal of the Chinese Medical Association : JCMA|June 9, 2004
Intravenous busulfan as preparative regimen in pediatric patients receiving hematopoietic stem cell transplantation: the preliminary experience in TaiwanMing-Yang Lee, Tzeon-Jye Chiou, Li-Yuan Bai, et al.
Springerplus|July 5, 2016
The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observationChang-Fang Chiu, Horng-Ren Yang, Mei-Due Yang, et al.
International Journal of Medical Sciences|March 3, 2025
A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cellsLi-Yuan Bai, Eman M E Dokla, Po-Chen Chu, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2013
Antitumor effects of BI-D1870 on human oral squamous cell carcinomaChang-Fang Chiu, Li-Yuan Bai, Naval Kapuriya, et al.
European Journal of Pharmacology|November 27, 2015
BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrestLi-Yuan Bai, Chang-Fang Chiu, Naval P Kapuriya, et al.
Marine Drugs|April 30, 2021
Antitumor Effects of a Sesquiterpene Derivative from Marine Sponge in Human Breast Cancer CellsLi-Yuan Bai, Jui-Hsin Su, Chang-Fang Chiu, et al.
Annals of Hematology|May 17, 2011
Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cellsSu-Peng Yeh, Wen-Jyi Lo, Chiao-Lin Lin, et al.
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphomaChing-Yun Hsieh, Hsin-Hui Huang, Chen-Yuan Lin, et al.
Journal of Medicinal Chemistry|August 10, 2011
Identification and characterization of a novel integrin-linked kinase inhibitorSu-Lin Lee, En-Chi Hsu, Chih-Chien Chou, et al.
Oncotarget|April 19, 2017
OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signalingWan-Chi Tsai, Li-Yuan Bai, Yi-Jin Chen, et al.
Journal of the Chinese Medical Association : JCMA|June 9, 2004
Intravenous busulfan as preparative regimen in pediatric patients receiving hematopoietic stem cell transplantation: the preliminary experience in TaiwanMing-Yang Lee, Tzeon-Jye Chiou, Li-Yuan Bai, et al.
Springerplus|July 5, 2016
The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observationChang-Fang Chiu, Horng-Ren Yang, Mei-Due Yang, et al.
International Journal of Medical Sciences|March 3, 2025
A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cellsLi-Yuan Bai, Eman M E Dokla, Po-Chen Chu, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2013
Antitumor effects of BI-D1870 on human oral squamous cell carcinomaChang-Fang Chiu, Li-Yuan Bai, Naval Kapuriya, et al.
European Journal of Pharmacology|November 27, 2015
BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrestLi-Yuan Bai, Chang-Fang Chiu, Naval P Kapuriya, et al.
Marine Drugs|April 30, 2021
Antitumor Effects of a Sesquiterpene Derivative from Marine Sponge in Human Breast Cancer CellsLi-Yuan Bai, Jui-Hsin Su, Chang-Fang Chiu, et al.
Annals of Hematology|May 17, 2011
Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cellsSu-Peng Yeh, Wen-Jyi Lo, Chiao-Lin Lin, et al.
Pageof 16